Analysis of Long-term (Investment) Activity Ratios
Quarterly Data
Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Long-term Activity Ratios (Summary)
Align Technology Inc., long-term (investment) activity ratios (quarterly data)
Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
| Long-term activity ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Align Technology Inc. net fixed asset turnover ratio deteriorated from Q1 2023 to Q2 2023 but then improved from Q2 2023 to Q3 2023 exceeding Q1 2023 level. |
| Net fixed asset turnover (including operating lease, right-of-use asset) | An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). | Align Technology Inc. net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from Q1 2023 to Q2 2023 but then improved from Q2 2023 to Q3 2023 exceeding Q1 2023 level. |
| Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Align Technology Inc. total asset turnover ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023. |
| Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Align Technology Inc. equity turnover ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023. |
Net Fixed Asset Turnover
Align Technology Inc., net fixed asset turnover calculation (quarterly data)
| Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||||||
| Net revenues | 960,214) | 1,002,173) | 943,147) | 901,515) | 890,348) | 969,553) | 973,219) | 1,031,099) | 1,015,906) | 1,010,808) | 894,771) | 834,520) | 734,144) | 352,314) | 550,963) | 649,787) | 607,341) | 600,697) | 548,971) | 534,020) | 505,289) | 490,259) | 436,924) | |||||||
| Property, plant and equipment, net | 1,268,388) | 1,279,042) | 1,262,815) | 1,231,855) | 1,199,880) | 1,182,444) | 1,140,922) | 1,081,926) | 1,002,769) | 960,852) | 763,870) | 734,721) | 703,657) | 668,951) | 663,491) | 631,730) | 606,581) | 599,611) | 575,267) | 521,329) | 491,630) | 447,933) | 400,528) | |||||||
| Long-term Activity Ratio | ||||||||||||||||||||||||||||||
| Net fixed asset turnover1 | 3.00 | 2.92 | 2.93 | 3.03 | 3.22 | 3.37 | 3.53 | 3.65 | 3.75 | 3.62 | 3.69 | 3.36 | 3.25 | 3.23 | 3.63 | 3.81 | 3.78 | 3.65 | 3.61 | 3.77 | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||||
| Net Fixed Asset Turnover, Competitors2 | ||||||||||||||||||||||||||||||
| Abbott Laboratories | 4.18 | 4.26 | 4.47 | 4.76 | 5.18 | 5.17 | 5.00 | 4.81 | 4.79 | 4.56 | 4.23 | 3.83 | 3.74 | 3.77 | 4.06 | 3.97 | — | — | — | — | — | — | — | |||||||
| Cigna Group | 48.12 | 47.67 | 47.44 | 47.53 | 47.84 | 48.61 | 47.95 | 46.73 | 41.42 | 40.56 | 39.29 | 37.85 | 37.05 | 36.02 | 35.37 | 34.45 | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | 26.62 | 26.00 | 25.63 | 24.98 | 24.90 | 24.05 | 23.26 | 22.56 | 22.24 | 21.90 | 21.42 | 21.25 | 21.48 | 21.52 | 21.49 | 21.24 | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | 39.41 | 36.19 | 36.14 | 36.07 | 36.22 | 36.17 | 35.81 | 34.94 | 34.54 | 34.17 | 34.94 | 34.69 | 34.61 | 32.74 | 32.30 | 32.92 | — | — | — | — | — | — | — | |||||||
| Humana Inc. | 30.35 | 29.59 | 29.40 | 28.71 | 28.37 | 28.64 | 27.05 | 26.97 | 27.83 | 29.47 | 31.04 | 32.05 | 32.90 | 33.07 | 33.20 | 32.93 | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | 2.23 | 2.35 | 2.49 | 2.62 | 2.73 | 2.83 | 3.00 | 3.04 | 3.16 | 3.13 | 2.86 | 2.76 | 2.85 | 3.00 | 3.36 | 3.52 | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 5.66 | 5.82 | 5.88 | 5.85 | 6.05 | 6.13 | 6.12 | 5.77 | 5.56 | 5.64 | 5.72 | 5.99 | 6.52 | 6.50 | 6.51 | 6.54 | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | 32.18 | 31.60 | 31.35 | 31.81 | 33.07 | 32.33 | 32.16 | 31.81 | 31.77 | 30.94 | 30.76 | 29.64 | 30.80 | 30.30 | 29.91 | 27.60 | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q3 2023 Calculation
Net fixed asset turnover
= (Net revenuesQ3 2023
+ Net revenuesQ2 2023
+ Net revenuesQ1 2023
+ Net revenuesQ4 2022)
÷ Property, plant and equipment, net
= (960,214 + 1,002,173 + 943,147 + 901,515)
÷ 1,268,388 = 3.00
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Align Technology Inc. net fixed asset turnover ratio deteriorated from Q1 2023 to Q2 2023 but then improved from Q2 2023 to Q3 2023 exceeding Q1 2023 level. |
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)
Align Technology Inc., net fixed asset turnover (including operating lease, right-of-use asset) calculation (quarterly data)
| Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||||||
| Net revenues | 960,214) | 1,002,173) | 943,147) | 901,515) | 890,348) | 969,553) | 973,219) | 1,031,099) | 1,015,906) | 1,010,808) | 894,771) | 834,520) | 734,144) | 352,314) | 550,963) | 649,787) | 607,341) | 600,697) | 548,971) | 534,020) | 505,289) | 490,259) | 436,924) | |||||||
| Property, plant and equipment, net | 1,268,388) | 1,279,042) | 1,262,815) | 1,231,855) | 1,199,880) | 1,182,444) | 1,140,922) | 1,081,926) | 1,002,769) | 960,852) | 763,870) | 734,721) | 703,657) | 668,951) | 663,491) | 631,730) | 606,581) | 599,611) | 575,267) | 521,329) | 491,630) | 447,933) | 400,528) | |||||||
| Operating lease right-of-use assets, net | 118,966) | 125,881) | 117,889) | 118,880) | 116,031) | 117,912) | 125,252) | 121,257) | 92,727) | 93,425) | 82,435) | 82,553) | 83,386) | 68,578) | 70,366) | 56,244) | 53,923) | 57,269) | 56,384) | —) | —) | —) | —) | |||||||
| Property, plant and equipment, net (including operating lease, right-of-use asset) | 1,387,354) | 1,404,923) | 1,380,704) | 1,350,735) | 1,315,911) | 1,300,356) | 1,266,174) | 1,203,183) | 1,095,496) | 1,054,277) | 846,305) | 817,274) | 787,043) | 737,529) | 733,857) | 687,974) | 660,504) | 656,880) | 631,651) | 521,329) | 491,630) | 447,933) | 400,528) | |||||||
| Long-term Activity Ratio | ||||||||||||||||||||||||||||||
| Net fixed asset turnover (including operating lease, right-of-use asset)1 | 2.74 | 2.66 | 2.68 | 2.76 | 2.94 | 3.07 | 3.18 | 3.29 | 3.43 | 3.30 | 3.33 | 3.02 | 2.91 | 2.93 | 3.28 | 3.50 | 3.47 | 3.33 | 3.29 | 3.77 | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||||
| Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2 | ||||||||||||||||||||||||||||||
| CVS Health Corp. | 11.33 | 11.01 | 10.81 | 10.46 | 10.17 | 9.80 | 9.44 | 9.09 | 8.55 | 8.37 | 8.15 | 8.04 | 8.08 | 8.02 | 7.95 | 7.77 | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q3 2023 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset)
= (Net revenuesQ3 2023
+ Net revenuesQ2 2023
+ Net revenuesQ1 2023
+ Net revenuesQ4 2022)
÷ Property, plant and equipment, net (including operating lease, right-of-use asset)
= (960,214 + 1,002,173 + 943,147 + 901,515)
÷ 1,387,354 = 2.74
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover (including operating lease, right-of-use asset) | An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). | Align Technology Inc. net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from Q1 2023 to Q2 2023 but then improved from Q2 2023 to Q3 2023 exceeding Q1 2023 level. |
Total Asset Turnover
Align Technology Inc., total asset turnover calculation (quarterly data)
| Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||||||
| Net revenues | 960,214) | 1,002,173) | 943,147) | 901,515) | 890,348) | 969,553) | 973,219) | 1,031,099) | 1,015,906) | 1,010,808) | 894,771) | 834,520) | 734,144) | 352,314) | 550,963) | 649,787) | 607,341) | 600,697) | 548,971) | 534,020) | 505,289) | 490,259) | 436,924) | |||||||
| Total assets | 6,318,551) | 6,144,550) | 5,901,448) | 5,947,947) | 5,912,802) | 5,810,119) | 5,943,414) | 5,942,110) | 5,650,109) | 5,395,568) | 5,069,782) | 4,829,683) | 4,415,091) | 4,025,857) | 3,964,840) | 2,500,702) | 2,350,380) | 2,346,017) | 2,234,430) | 2,052,458) | 1,928,405) | 1,916,589) | 1,782,731) | |||||||
| Long-term Activity Ratio | ||||||||||||||||||||||||||||||
| Total asset turnover1 | 0.60 | 0.61 | 0.63 | 0.63 | 0.65 | 0.69 | 0.68 | 0.67 | 0.66 | 0.64 | 0.56 | 0.51 | 0.52 | 0.54 | 0.61 | 0.96 | 0.97 | 0.93 | 0.93 | 0.96 | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||||
| Total Asset Turnover, Competitors2 | ||||||||||||||||||||||||||||||
| Abbott Laboratories | 0.55 | 0.55 | 0.56 | 0.59 | 0.62 | 0.61 | 0.60 | 0.57 | 0.57 | 0.55 | 0.51 | 0.48 | 0.47 | 0.46 | 0.48 | 0.47 | — | — | — | — | — | — | — | |||||||
| Cigna Group | 1.26 | 1.23 | 1.23 | 1.25 | 1.24 | 1.17 | 1.15 | 1.11 | 1.09 | 1.07 | 1.06 | 1.02 | 0.97 | 0.96 | 0.99 | 0.98 | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | 1.38 | 1.35 | 1.38 | 1.41 | 1.36 | 1.33 | 1.28 | 1.25 | 1.21 | 1.20 | 1.18 | 1.16 | 1.14 | 1.12 | 1.13 | 1.15 | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | 1.52 | 1.51 | 1.46 | 1.51 | 1.48 | 1.47 | 1.42 | 1.41 | 1.35 | 1.33 | 1.29 | 1.39 | 1.34 | 1.28 | 1.31 | 1.33 | — | — | — | — | — | — | — | |||||||
| Humana Inc. | 1.81 | 1.73 | 1.74 | 2.15 | 1.80 | 1.91 | 1.86 | 1.87 | 1.78 | 2.08 | 2.08 | 2.17 | 1.90 | 1.82 | 1.94 | 2.21 | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | 0.47 | 0.48 | 0.49 | 0.48 | 0.46 | 0.44 | 0.43 | 0.42 | 0.42 | 0.42 | 0.39 | 0.39 | 0.41 | 0.43 | 0.47 | 0.46 | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 0.33 | 0.33 | 0.35 | 0.35 | 0.35 | 0.35 | 0.34 | 0.32 | 0.29 | 0.29 | 0.30 | 0.32 | 0.33 | 0.34 | 0.34 | 0.34 | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | 1.26 | 1.23 | 1.18 | 1.31 | 1.29 | 1.32 | 1.33 | 1.34 | 1.30 | 1.29 | 1.27 | 1.30 | 1.31 | 1.28 | 1.29 | 1.38 | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q3 2023 Calculation
Total asset turnover
= (Net revenuesQ3 2023
+ Net revenuesQ2 2023
+ Net revenuesQ1 2023
+ Net revenuesQ4 2022)
÷ Total assets
= (960,214 + 1,002,173 + 943,147 + 901,515)
÷ 6,318,551 = 0.60
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Align Technology Inc. total asset turnover ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023. |
Equity Turnover
Align Technology Inc., equity turnover calculation (quarterly data)
| Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||||||
| Net revenues | 960,214) | 1,002,173) | 943,147) | 901,515) | 890,348) | 969,553) | 973,219) | 1,031,099) | 1,015,906) | 1,010,808) | 894,771) | 834,520) | 734,144) | 352,314) | 550,963) | 649,787) | 607,341) | 600,697) | 548,971) | 534,020) | 505,289) | 490,259) | 436,924) | |||||||
| Stockholders’ equity | 3,801,866) | 3,638,301) | 3,480,049) | 3,601,358) | 3,694,622) | 3,599,081) | 3,666,852) | 3,622,714) | 3,516,762) | 3,384,410) | 3,393,576) | 3,233,865) | 3,033,471) | 2,845,045) | 2,852,989) | 1,346,169) | 1,305,549) | 1,373,682) | 1,255,704) | 1,252,891) | 1,192,983) | 1,218,959) | 1,127,460) | |||||||
| Long-term Activity Ratio | ||||||||||||||||||||||||||||||
| Equity turnover1 | 1.00 | 1.03 | 1.06 | 1.04 | 1.05 | 1.11 | 1.10 | 1.09 | 1.07 | 1.03 | 0.83 | 0.76 | 0.75 | 0.76 | 0.84 | 1.79 | 1.75 | 1.59 | 1.66 | 1.57 | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||||
| Equity Turnover, Competitors2 | ||||||||||||||||||||||||||||||
| Abbott Laboratories | 1.07 | 1.08 | 1.12 | 1.19 | 1.26 | 1.25 | 1.26 | 1.20 | 1.23 | 1.19 | 1.11 | 1.06 | 1.03 | 1.03 | 1.06 | 1.03 | — | — | — | — | — | — | — | |||||||
| Cigna Group | 4.13 | 4.07 | 4.09 | 4.00 | 3.98 | 3.88 | 3.81 | 3.66 | 3.56 | 3.40 | 3.36 | 3.16 | 3.24 | 3.24 | 3.39 | 3.36 | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | 4.66 | 4.65 | 4.62 | 4.53 | 4.45 | 4.08 | 4.05 | 3.87 | 3.82 | 3.79 | 3.81 | 3.86 | 3.86 | 3.87 | 4.01 | 4.00 | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | 4.36 | 4.31 | 4.27 | 4.29 | 4.22 | 4.13 | 3.97 | 3.80 | 3.71 | 3.65 | 3.65 | 3.64 | 3.43 | 3.26 | 3.41 | 3.25 | — | — | — | — | — | — | — | |||||||
| Humana Inc. | 5.98 | 5.82 | 5.74 | 6.04 | 5.62 | 5.77 | 5.63 | 5.15 | 4.96 | 5.34 | 5.48 | 5.54 | 4.65 | 4.86 | 5.44 | 5.35 | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | 0.55 | 0.56 | 0.57 | 0.56 | 0.53 | 0.50 | 0.49 | 0.48 | 0.48 | 0.48 | 0.45 | 0.45 | 0.47 | 0.50 | 0.54 | 0.54 | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 0.60 | 0.59 | 0.59 | 0.60 | 0.60 | 0.61 | 0.61 | 0.59 | 0.55 | 0.56 | 0.56 | 0.57 | 0.60 | 0.61 | 0.61 | 0.61 | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | 4.22 | 4.19 | 4.10 | 4.14 | 4.19 | 4.18 | 4.06 | 3.98 | 3.95 | 3.92 | 3.94 | 3.90 | 3.85 | 3.87 | 4.29 | 4.17 | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q3 2023 Calculation
Equity turnover
= (Net revenuesQ3 2023
+ Net revenuesQ2 2023
+ Net revenuesQ1 2023
+ Net revenuesQ4 2022)
÷ Stockholders’ equity
= (960,214 + 1,002,173 + 943,147 + 901,515)
÷ 3,801,866 = 1.00
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Align Technology Inc. equity turnover ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023. |